The BPCA was enacted to address the critical issue of the lack of adequate pediatric labeling for many drugs. Previously, many medications used to treat children were not formally tested for pediatric use, leading to potential safety and efficacy concerns. By offering incentives, the BPCA aims to fill these knowledge gaps and ensure that children have access to medications that are appropriately tested for their age group.
